Potent Retinoid X Receptor Ligands
J ournal of Medicinal Chemistry, 2001, Vol. 44, No. 14 2303
induce apoptosis in leukemia cells. J . Med. Chem. 1995, 38,
Ack n ow led gm en t. We thank Prof. J oseph Ziller of
University of California at Irvine for the X-ray structure
determination of compound 9 and Hai Nguyen for mass
spectral analysis. We also thank Dr. J ia-Hao Xiao and
Dr. Elliott Klein for conducting the receptor trans-
activation and binding assays.
3
146-3155. (i) Apfel, C. M.; Kamber, M.; Klaus, M.; Mohr, P.;
Keidel, S.; LeMotte, P. K. Enhancement of HL-60 differentiation
by a new class of retinoids with selective activity on retinoid X
receptor. J . Biol. Chem. 1995, 270, 30765-72. (j) Vuligonda, V.;
Lin, Y.; Chandraratna, R. A. S. Synthesis of highly potent RXR-
specific retinoids: The use of a cyclopropyl group as a double
bond isostere. Bioorg. Med. Chem. Lett. 1996, 6, 213-218. (k)
Beard, R. L.; Colon, D. F.; Song, T. K.; Davies, P. J . A.; Kochar,
D. M.; Chandraratna, R. A. S. Synthesis and structure-activity
relationships of retinoid X receptor selective diaryl sulfide
analogs of retinoic acid. J . Med. Chem. 1996, 39, 3556-3563. (l)
Brooks, C. S.; Kazmer, S.; Levin, A. A.; Yen, A. Myeloid
differentiation and retinoblastoma phosphorylation changes in
HL-60 cells induced by retinoic acid receptor and retinoid X
receptor selective retinoic acid analogs. Blood 1996, 87, 227-
37. (m) Farmer, L. J .; Zhi, L.; J eong, S.; Kallel, A. E.; Canan-
Koch, S. S.; Croston, G. E.; Flatten, K. S.; Heyman, R. A.;
Nadzan, A. M. Synthesis and structure-acitivity relationships
of potent conformationally restricted retinoid X receptor ligands.
Bioorg. Med. Chem. Lett. 1997, 7, 2747-2752. (n) Vuligonda,
V.; Chandraratna, R. A. S. 2,4-Pentadienoic acid derivatives
having retinoid-like biological activity. U.S. Patent 5,663,367,
1997; Chem. Abstr. 1999 131, 73444. (o) Farmer, L. J .; J eong,
S.; Kallel, A. E.; Canan-Koch, S. S.; Croston, G. E.; Flatten, K.
S.; Heyman, R. A.; Nadzan, A. M. Synthesis and structure-
acitivity relationships of potent retinoid X receptor ligands.
Bioorg. Med. Chem. Lett. 1997, 7, 2393-2398. (p) Canan Koch,
S. S.; Dardashti, L. J .; Cesario, R. M.; Croston, G. E.; Boehm,
M. F.; Heyman, R. A.; Nadzan, A. M. Identification of first
retinoid X receptor homodimer antagonist. J . Med. Chem. 1999,
42, 742-750. (q) Vuligonda, V.; Garst, M.; Chandraratna, R. A.
S. Stereoselective synthesis and receptor activity of conforma-
tionally defined retinoid X receptor selective ligands. Bioorg.
Med. Chem. Lett. 1999, 9, 589-594.
Refer en ces
(
1) Mangelsdorf, D. J .; Umesono, K.; Evans, R. M. The Retinoid
Receptors. In THE RETINOIDS: Biology, Chemistry and Medi-
cine, 2nd ed.: Sporn, M., B., Goodman, D. S., Eds.; Raven Press
Ltd.: New York, 1994; pp 319-349.
(
2) (a) Petkovich, M.; Brand, N. J .; Krust, A.; Chambon, P. A human
retinoic acid receptor which belongs to the family of nuclear
receptors. Nature 1987, 330, 444-450. (b) Giguere, U.; Ong, E.
S.; Segui, P.; Evans, R. M. Identification of a receptor for the
morphogen retinoic acid. Nature 1987, 330, 624-629. (c) Brand,
N. J .; Petkovich, M.; Krust, A.; Chambon, P.; deThe, H.; Marchio,
A.; Dejean, A. Identification of a second heman retinoic acid
receptor. Nature 1988, 332, 850-853. (d) Krust, A.; Kastner, P.;
Petkovich, M.; Zelent, A.; Chambon, P. A third human retinoic
acid receptor, hRAR-γ. Proc. Natl. Acad. Sci. U.S.A. 1989, 86,
5
310-5314.
(
3) (a) Mangelsdorf, D. J .; Ong, O. S.; Dyck, J . A.; Evans, R. M.
Nuclear receptor that identifies a novel retinoic acid response
pathway. Nature 1990, 345, 224-229. (b) Mangelsdorf, D. J .;
Borgmeyer, U.; Heyman, R. A.; Zhou, J . Y.; Ong, E. S.; Oro, A.
E.; Kakizuka, A.; Evans, R. M. Characterization of three RXR
genes that mediate the action of 9-cis retinoic acid. Genes Dev.
1
992, 6, 329-344.
(
4) (a) Heyman, R. A.; Mangelsdorf, D. J .; Dyck, J . A.; Stein, R. B.;
Eichele, G.; Evans, R. M.; Thaller, C. 9-Cis retinoic acid is a high
affinity ligand for the retinoid X receptor. Cell 1992, 68, 397-
(8) Kagechika, H.; Himi, T.; Namikawa, K.; Kawachi, E.; Hashimoto,
Y.; Shudo, K. Retinobenzoic acids 3. Structure activity-relation-
ships of retinoidal azobenzene-4-carboxylic acids and stilbene
4-carboxylic acids. J . Med. Chem. 1989, 32, 1098-108.
(9) Ukaji, Y.; Nishimura, M.; Fujisawa, T. Enantioselective con-
struction of cyclopropane rings via asymmetric Simmons-Smith
reaction of allylic alcohols. Chem. Lett. 1992, 61-64.
4
06. (b) Levin, A. A.; Sturzenbecker, L. J .; Kazmer, S.; Bosa-
kowski, T.; Huselton, C.; Allenby, G.; Speck, J .; Kratzeisen, C.
I.; Rosenberger, M.; Lovey, A.; Grippo, J . F. 9-Cis retinoic acid
stereoisomer binds and activates the nuclear receptor RXRR.
Nature 1992, 355, 359-361.
(
5) Zhang, X.-K.; Lehmann, J .; Hoffman, B.; Dawson, M. I.; Cam-
eron, J .; Graupner, G.; Hermann, T.; Tran, P.; Pfahl, M.
Homodimer formation of retinoid X receptor induced by 9-cis
retinoic acid. Nature 1992, 358, 587-361.
(10) The aldehydes 14 and 15 are relatively unstable and were
generally used immediately after they were synthesized.
(11) (a) Christensen, K.; Estes, P. A.; Onate, S. A.; Beck, C. A.;
DeMarzo, A.; Altman, M.; Lieberman, B. A.; St. J ohn, J .;
Nordeen, S. K.; Edwards, D. P. Characterization and functional
properties of the A and B forms of human progesterone receptors
synthesized in baculovirus system. Mol. Endocrinol. 1991, 5,
1755-70. (b) Cheng, Y. C.; Prussof, W. H. The relationship
(
6) (a) Mukherjee, R.; Davies, P. J . A.; Crombie, D. L.; Bischoff, E.
D.; Cesario, R. M.; J ow, L.; Hamann, L. G.; Boehm, M. F.;
Mondon, C. E.; Nadzan, A. M.; Paterniti, J . R.; Heyman, R. A.
Sensitization of diabetic and obese mice to insulin by retinoid X
receptor agonists. Nature 1997, 386, 407-410. (b) Repa, J . J .;
Turley, S. D.; Lobaccaro, M. A.; Medina, J .; Li, L.; Lustig, K.;
Heyman, R. A.; Dietschy, J . M.; Mangelsdorf, D. J . Regulation
of absorption and ABC1-mediated efflux of cholesterol by RXR
heterodimers. Science 2000, 289, 1524-1529.
between the inhibitory constant K and the concentration of
i
inhibitor which causes 50% inhibition. Biochem. Pharmacol.
1973, 22, 3099-3108. (c) Allegretto, E. A.; McClurg, M. R.;
Lazarchik, S. B.; Clemm, D. L.; Kerner, S. A.; Elgort, M. G.;
Boehm, M. F.; White, S. K.; Pike, J . W.; Heyman, R. A.
Transactivation properties of retinoic acid and retinoid X recep-
tors in mammalian cells and yeast. Correlation with hormone
binding and effects of metabolism. J . Biol. Chem. 1993, 268,
26625-26633.
(
7) (a) Lehmann, J . M.; J ong, L.; Fanjul, A.; Cameron, J . F.; Lu, X.
P.; Haefner, P.; Dawson, M. I.; Pfahl, M. Retinoids selective for
retinoid X receptor response pathways. Science 1992, 258, 1944-
1
946. (b) Boehm M. F.; McClurg, M. R.; Pathirana, C.; Man-
gelsdorf, D.; White, S. K.; Hebert, J .; Winn, D.; Goldman, M. E.;
Heyman, R. A. Synthesis of high specific activity [ H]-9-cis
retinoic acid and its application for identifying retinoids with
3
(12) Umesono, K.; Giguere, V.; Glass, C. K.; Rosenfeld, M. G.; Evans,
R. M. Retinoic acid and thyroid hormone induce gene expression
through a common responsive element. Nature 1988, 336, 262-
265.
unusual binding properties. J . Med. Chem. 1994, 37, 408-414.
(c) Beard, R. L.; Gil, D. W.; Marler, D. K.; Henry, E.; Colon, D.
F.; Gillett, S. J .; Arefieg, T.; Breen, T. S.; Krauss, H.; Davies, P.
J . A.; Chandraratna, R. A. S. Structural basis for the differential
RXR and RAR activity of stilbene retinoid analogs. Bioorg. Med.
Chem. Lett. 1994, 4, 1447-52. (d) J ong, L.; Lehmann, J . M.;
Hobbs, P. D.; Harlev, E.; Huffman, J . C.; Pfahl, M.; Dawson, M.
I. Conformational effects on retinoid receptor selectivity. 1. Effect
of 9-double bond geometry on retinoid X receptor activity. J . Med.
Chem. 1993, 36, 2605-2613. (e) Beard, R. L.; Chandraratna, R.
A. S.; Colon, D. F.; Gillett, S. J .; Henry, E.; Marler, D. K.; Song,
T.; Denys, L.; Garst, M. E.; Arefieg, T.; Klein, E.; Gil, D. W.;
Wheeler, L.; Kochar, D.; Davies, P. J. A. Synthesis and structure-
activity relationships of stilbene retinoid analogs substituted
with heteroaromatic carboxylic acids. J . Med. Chem. 1995, 38,
(13) Fujiwara, T.; Yoshioka, S.; Yoshioka, T.; Ushiyama, I.; Horikoshi,
H. Characterization of new oral anti-diabetic agent CS-045.
Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes
1988, 37, 1549-58.
(14) Chen, H.; Charlat, O.; Tartaglia, L. A.; Woolf, E. A.; Weng, X.;
Ellis, S. J .; Lakey, N. D.; Culpepper, J .; Moore, K. J .; Breitbart,
R. E.; Duyk, G. M.; Tepper, R. I.; Morgenstern, J . P. Evidence
that the diabetes gene encodes the leptin receptor: Identification
of a mutation in the leptin receptor gene in db/db mice. Cell 1996
84, 491-495.
(15) In a separate study, a two week treatment with compound 2 at
4 mg/kg lowered blood glucose levels by 65% compared to control
animals, demonstrating the long term therapeutic effects of this
compound.
2
820-2829. (f) Beard, R. L.; Colon, D. F.; Klein, E. S.; Vorse, K.
A.; Chandraratna, R. A. S. Differential RXR and RAR activity
of stilbene retinoid analogs bearing thiazole and imidazole
carboxylic acids. Bioorg. Med. Chem. Lett. 1995, 5, 2729-34. (g)
Dawson, M. I.; J ing, L.; Hobbs, P.; Cameron, J . F.; Chao, W.;
Pfahl, M.; Lee, M.-O.; Shroot, B.; Pfahl, M. Conformational
effects on retinoid receptor selectivity. 2. Effects of retinoid
bridging group on retinoid X receptor activity and selectivity.
J . Med. Chem. 1995, 38, 3368-3383. (h) Boehm, M. F.; Zhang,
L.; Zhi, L.; McClurg, M. R.; Berger, E.; Wagoner, M.; Mais, D.;
Suto, C. M.; Davies, P. J . A.; Heyman, R. A.; Nadzan, A. M.
Design and synthesis of potent retinoid X receptor ligands that
(16) Klein, E. S.; Pino, M. E.; J ohnson, A. A.; Davis, P. J . A.; Nagpal,
S.; Thacher, S. M.; Krasinski, G.; Chandraratna, R. A. S.
Identification and functional separation of retinoic acid receptor
neutral antagonists and inverse agonists. J . Biol. Chem. 1996,
271, 22692-22696.
(17) XSCANS Software Users Guide, Version 2.2; Siemens Industrial
Automation, Inc.: Madison, WI, 1994
(18) Sheldrick, G. M. Bruker Analytical X-ray Instruments; Bruker
Inc.: Madison, WI, 1999.
J M0100584